About Us
We explore innovative therapies by repurposing and improving existing drugs, aiming to bring proven treatments to patients faster. Our approach combines clinical insight, real-world data, and advanced technology to help address urgent healthcare needs—without the delays of traditional drug development.
What We Do
We repurpose underused or off-patent compounds, optimize drug delivery methods, and use real-world data to guide development. Our goal is to improve the safety, effectiveness, and accessibility of therapies already known to be clinically active—delivering greater impact with greater efficiency.
Flagship Innovation
Our lead candidate is a biodegradable CBD implant designed to provide consistent, long-acting therapeutic exposure for chronic pain and neurodegenerative disorders. This patent-pending platform aims to become the first FDA-approved CBD implant, addressing the absorption challenges of conventional CBD products.
Why It Matters
Many patients with chronic or hard-to-treat conditions face limited, ineffective, or inaccessible treatment options. By focusing on real-world need, optimized delivery, and compounds with untapped clinical potential, our model seeks to reduce risk, accelerate timelines, and improve patient outcomes.
Leadership & Vision
Qualthera Pharmaceuticals was founded as an extension of Qualthera Health Corporation, led by Donald Prentiss and supported by a cross-functional team of experts. Together, we bridge the gap between personalized care and scalable therapeutic innovation—all in pursuit of delivering quality therapy for life.